Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

Market Cap	201.17B
Revenue (ttm)	66.40B
Net Income (ttm)	-28.37B
Shares Out	49.55M
EPS (ttm)	-566.79
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	151,600
Average Volume	296,139
Open	4,050.00
Previous Close	4,130.00
Day's Range	4,000.00 - 4,150.00
52-Week Range	3,870.00 - 9,520.00
Beta	-0.87
RSI	40.69
Earnings Date	Mar 20, 2026

About Vivozon Pharmaceutical

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as well as lights for parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps, LED flat lamps, LED...

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 307
• Stock Exchange: KOSDAQ
• Ticker Symbol: 082800

Financial Performance

In 2024, Vivozon Pharmaceutical's revenue was 87.60 billion, an increase of 22.83% compared to the previous year's 71.32 billion. Losses were -9.98 billion, 197.3% more than in 2023.